A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer’s Disease ; volume:38 ; number:7 ; day:5 ; month:6 ; year:2024 ; pages:493-505 ; date:7.2024
CNS drugs ; 38, Heft 7 (5.6.2024), 493-505, 7.2024
- Urheber
-
Rosenbloom, Michael H.
O’Donohue, Tricia
Zhou-Clark, Domi
Mala, Deepashni
Frazier, Andrew
Tarrant, Michael
Modrijan, Michelle
Riveira, Melora
Chapman, Darla
Griffin, Yvonne
Shakalis, Lauren
Grabowski, Thomas J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-024-01097-w
- URN
-
urn:nbn:de:101:1-2408271259090.909865978591
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rosenbloom, Michael H.
- O’Donohue, Tricia
- Zhou-Clark, Domi
- Mala, Deepashni
- Frazier, Andrew
- Tarrant, Michael
- Modrijan, Michelle
- Riveira, Melora
- Chapman, Darla
- Griffin, Yvonne
- Shakalis, Lauren
- Grabowski, Thomas J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Automated detection of early-stage Alzheimer’s Disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Automated detection of early-stage Alzheimer’s Disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Automated detection of early-stage Alzheimer’s Disease
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease